1Braun S.Safety of calcium channel blockers:perspective on controversy[J].Cardiology,1997,88(Suppl 3):1
2Pickering TG,Hall JE,Appel LJ,et al.Subcommittee of Professional and Public Education of the American Heart Association Coumcil on highblood pressure research[J].Hypertension,2005,45(1):142-161
3Gong LS,Zhang WH,Zhu YJ,et al.Shanghai trial of nifedipine in theelderly(STONE)[J].Hypertens,1996,14:1237
4Sidorenko BA,stetsenko TM,Preobrazhenskii DV,et al.Antagonisty kal′tsiia tret′ego pokoleniia.V fokuse-latsidipin.Third generation of calcium antagonists:focus on lacidipine[J].Cardiologiia,2002,42(12):81-90
5Zanchetti A,Bond MG,Hennig M,et al.Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis:Principal Results of the European Lacidipine Study on Atherosclerosis(ELSA),a Randomized,Double-Blind,Long-Term Trial[J].Circulation,2002,106(19):2422-2427
6Cristofori P,Lanzoni A,Gaviraghi G,et al.Antiatherosclerotic activity of the calcium antagonist lacidipine in cholesterol-fed hamsters[J].Biomed-Pharmacother,2000,54(2):93-99
7Kyselovic J,Krenek P,Wibo M,et al.Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats[J].Br J pharmacol,2001,134(7):1516-1522
8McCormack PL, Wagstaff AJ. Lacidipine : a review of its use in the management of hypertension [ J ]. Drugs, 2003,63 (21) : 2327- 2356.
9Cominacini L, Fratta Pasini A, Garhin U, et al. Antioxidant activity of different dihydropytldines [ J ]. Biochem Biophys Res Commun, 2003,302 (4) :679-684.
10Taddei S, Virdis A, Ghiadoni L, et al. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients [ J ]. Hypertension, 1997,30(6) : 1606-1612.
